Main
>
ONCOLOGY (**)
>
Lung>NSCLC>EGFR+>MET>***
>
Treatment
>
Co: UK. A. Osimertinib
>
(*) CA 2nd Line OK: 2016. 07.11.
(*) CA 2nd Line OK: 2016. 07.11.'s products
This section has no products